Global Prescription Dermatological Drugs Market Size, Status and Forecast 2025

Publisher Name :
Date: 12-Jun-2018
No. of pages: 95
Inquire Before Buying

This report studies the global Prescription Dermatological Drugs market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Prescription Dermatological Drugs market by companies, region, type and end-use industry.

In 2017, the global Prescription Dermatological Drugs market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025.

This report focuses on the global top players, covered

Johnson & Johnson

Merck

Bayer

Mylan Pharmaceuticals

Pfizer

F. Hoffmann-La Roche

Allergan

Valeant Pharmaceuticals

PharmaDerm Pharmaceuticals

Allergan Inamed Corporation

Market segment by Regions/Countries, this report covers

United States

Europe

China

Japan

Southeast Asia

India

Market segment by Type, the product can be split into

Anti-acne Drugs

Anti-aging Drugs

Dermatitis Drugs

Hair Loss Drugs

Psoriasis Drugs

Skin Cancer Drugs

Melasma Drugs

Seborrhea Drugs

Market segment by Application, split into

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

The study objectives of this report are:

To study and forecast the market size of Prescription Dermatological Drugs in global market.

To analyze the global key players, SWOT analysis, value and global market share for top players.

To define, describe and forecast the market by type, end use and region.

To analyze and compare the market status and forecast between China and major regions, namely, United States, Europe, China, Japan, Southeast Asia, India and Rest of World.

To analyze the global key regions market potential and advantage, opportunity and challenge, restraints and risks.

To identify significant trends and factors driving or inhibiting the market growth.

To analyze the opportunities in the market for stakeholders by identifying the high growth segments.

To strategically analyze each submarket with respect to individual growth trend and their contribution to the market

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Prescription Dermatological Drugs are as follows:

History Year: 2013-2017

Base Year: 2017

Estimated Year: 2018

Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders

Prescription Dermatological Drugs Manufacturers

Prescription Dermatological Drugs Distributors/Traders/Wholesalers

Prescription Dermatological Drugs Subcomponent Manufacturers

Industry Association

Downstream Vendors

Available Customizations

With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:

Regional and country-level analysis of the Prescription Dermatological Drugs market, by end-use.

Detailed analysis and profiles of additional market players.

Global Prescription Dermatological Drugs Market Size, Status and Forecast 2025

Table of Contents
Global Prescription Dermatological Drugs Market Size, Status and Forecast 2025
1 Industry Overview of Prescription Dermatological Drugs
1.1 Prescription Dermatological Drugs Market Overview
1.1.1 Prescription Dermatological Drugs Product Scope
1.1.2 Market Status and Outlook
1.2 Global Prescription Dermatological Drugs Market Size and Analysis by Regions (2013-2018)
1.2.1 United States
1.2.2 Europe
1.2.3 China
1.2.4 Japan
1.2.5 Southeast Asia
1.2.6 India
1.3 Prescription Dermatological Drugs Market by Type
1.3.1 Anti-acne Drugs
1.3.2 Anti-aging Drugs
1.3.3 Dermatitis Drugs
1.3.4 Hair Loss Drugs
1.3.5 Psoriasis Drugs
1.3.6 Skin Cancer Drugs
1.3.7 Melasma Drugs
1.3.8 Seborrhea Drugs
1.4 Prescription Dermatological Drugs Market by End Users/Application
1.4.1 Hospital Pharmacies
1.4.2 Retail Pharmacies
1.4.3 Online Pharmacies
2 Global Prescription Dermatological Drugs Competition Analysis by Players
2.1 Prescription Dermatological Drugs Market Size (Value) by Players (2013-2018)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 Company (Top Players) Profiles
3.1 Johnson & Johnson
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Prescription Dermatological Drugs Revenue (Million USD) (2013-2018)
3.2 Merck
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Prescription Dermatological Drugs Revenue (Million USD) (2013-2018)
3.3 Bayer
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Prescription Dermatological Drugs Revenue (Million USD) (2013-2018)
3.4 Mylan Pharmaceuticals
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Prescription Dermatological Drugs Revenue (Million USD) (2013-2018)
3.5 Pfizer
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Prescription Dermatological Drugs Revenue (Million USD) (2013-2018)
3.6 F. Hoffmann-La Roche
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Prescription Dermatological Drugs Revenue (Million USD) (2013-2018)
3.7 Allergan
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Prescription Dermatological Drugs Revenue (Million USD) (2013-2018)
3.8 Valeant Pharmaceuticals
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Prescription Dermatological Drugs Revenue (Million USD) (2013-2018)
3.9 PharmaDerm Pharmaceuticals
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Prescription Dermatological Drugs Revenue (Million USD) (2013-2018)
3.10 Allergan Inamed Corporation
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Prescription Dermatological Drugs Revenue (Million USD) (2013-2018)
4 Global Prescription Dermatological Drugs Market Size by Type and Application (2013-2018)
4.1 Global Prescription Dermatological Drugs Market Size by Type (2013-2018)
4.2 Global Prescription Dermatological Drugs Market Size by Application (2013-2018)
4.3 Potential Application of Prescription Dermatological Drugs in Future
4.4 Top Consumer/End Users of Prescription Dermatological Drugs
5 United States Prescription Dermatological Drugs Development Status and Outlook
5.1 United States Prescription Dermatological Drugs Market Size (2013-2018)
5.2 United States Prescription Dermatological Drugs Market Size and Market Share by Players (2013-2018)
5.3 United States Prescription Dermatological Drugs Market Size by Application (2013-2018)
6 Europe Prescription Dermatological Drugs Development Status and Outlook
6.1 Europe Prescription Dermatological Drugs Market Size (2013-2018)
6.2 Europe Prescription Dermatological Drugs Market Size and Market Share by Players (2013-2018)
6.3 Europe Prescription Dermatological Drugs Market Size by Application (2013-2018)
7 China Prescription Dermatological Drugs Development Status and Outlook
7.1 China Prescription Dermatological Drugs Market Size (2013-2018)
7.2 China Prescription Dermatological Drugs Market Size and Market Share by Players (2013-2018)
7.3 China Prescription Dermatological Drugs Market Size by Application (2013-2018)
8 Japan Prescription Dermatological Drugs Development Status and Outlook
8.1 Japan Prescription Dermatological Drugs Market Size (2013-2018)
8.2 Japan Prescription Dermatological Drugs Market Size and Market Share by Players (2013-2018)
8.3 Japan Prescription Dermatological Drugs Market Size by Application (2013-2018)
9 Southeast Asia Prescription Dermatological Drugs Development Status and Outlook
9.1 Southeast Asia Prescription Dermatological Drugs Market Size (2013-2018)
9.2 Southeast Asia Prescription Dermatological Drugs Market Size and Market Share by Players (2013-2018)
9.3 Southeast Asia Prescription Dermatological Drugs Market Size by Application (2013-2018)
10 India Prescription Dermatological Drugs Development Status and Outlook
10.1 India Prescription Dermatological Drugs Market Size (2013-2018)
10.2 India Prescription Dermatological Drugs Market Size and Market Share by Players (2013-2018)
10.3 India Prescription Dermatological Drugs Market Size by Application (2013-2018)
11 Market Forecast by Regions, Type and Application (2018-2025)
11.1 Global Prescription Dermatological Drugs Market Size (Value) by Regions (2018-2025)
11.1.1 United States Prescription Dermatological Drugs Revenue and Growth Rate (2018-2025)
11.1.2 Europe Prescription Dermatological Drugs Revenue and Growth Rate (2018-2025)
11.1.3 China Prescription Dermatological Drugs Revenue and Growth Rate (2018-2025)
11.1.4 Japan Prescription Dermatological Drugs Revenue and Growth Rate (2018-2025)
11.1.5 Southeast Asia Prescription Dermatological Drugs Revenue and Growth Rate (2018-2025)
11.1.6 India Prescription Dermatological Drugs Revenue and Growth Rate (2018-2025)
11.2 Global Prescription Dermatological Drugs Market Size (Value) by Type (2018-2025)
11.3 Global Prescription Dermatological Drugs Market Size by Application (2018-2025)
12 Prescription Dermatological Drugs Market Dynamics
12.1 Prescription Dermatological Drugs Market Opportunities
12.2 Prescription Dermatological Drugs Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Prescription Dermatological Drugs Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Prescription Dermatological Drugs Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 Research Finding/Conclusion
15 Appendix
Methodology
Analyst Introduction
Data Source
List of Tables and Figures
Figure Global Prescription Dermatological Drugs Market Size (Million USD) Status and Outlook (2013-2018)
Table Global Prescription Dermatological Drugs Revenue (Million USD) Comparison by Regions (2013-2018)
Figure Global Prescription Dermatological Drugs Market Share by Regions (2013-2018)
Figure United States Prescription Dermatological Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Europe Prescription Dermatological Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure China Prescription Dermatological Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Japan Prescription Dermatological Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Southeast Asia Prescription Dermatological Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure India Prescription Dermatological Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Table Global Prescription Dermatological Drugs Revenue (Million USD) and Growth Rate (%) Comparison by Product (2013-2018)
Figure Global Prescription Dermatological Drugs Revenue Market Share by Type in 2017
Figure Anti-acne Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Figure Anti-aging Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Figure Dermatitis Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Figure Hair Loss Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Figure Psoriasis Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Figure Skin Cancer Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Figure Melasma Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Figure Seborrhea Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Figure Global Prescription Dermatological Drugs Market Share by Application in 2017
Figure Prescription Dermatological Drugs Market Size (Million USD) and Growth Rate in Hospital Pharmacies (2013-2018)
Figure Prescription Dermatological Drugs Market Size (Million USD) and Growth Rate in Retail Pharmacies (2013-2018)
Figure Prescription Dermatological Drugs Market Size (Million USD) and Growth Rate in Online Pharmacies (2013-2018)
Table Prescription Dermatological Drugs Market Size (Million USD) by Players (2013-2018)
Figure Prescription Dermatological Drugs Market Size Share by Players in 2013
Figure Prescription Dermatological Drugs Market Size Share by Players in 2017
Table Johnson & Johnson Basic Information List
Table Prescription Dermatological Drugs Business Revenue (Million USD) of Johnson & Johnson (2013-2018)
Figure Johnson & Johnson Prescription Dermatological Drugs Business Revenue Market Share (2013-2018)
Table Merck Basic Information List
Table Prescription Dermatological Drugs Business Revenue (Million USD) of Merck (2013-2018)
Figure Merck Prescription Dermatological Drugs Business Revenue Market Share (2013-2018)
Table Bayer Basic Information List
Table Prescription Dermatological Drugs Business Revenue (Million USD) of Bayer (2013-2018)
Figure Bayer Prescription Dermatological Drugs Business Revenue Market Share (2013-2018)
Table Mylan Pharmaceuticals Basic Information List
Table Prescription Dermatological Drugs Business Revenue (Million USD) of Mylan Pharmaceuticals (2013-2018)
Figure Mylan Pharmaceuticals Prescription Dermatological Drugs Business Revenue Market Share (2013-2018)
Table Pfizer Basic Information List
Table Prescription Dermatological Drugs Business Revenue (Million USD) of Pfizer (2013-2018)
Figure Pfizer Prescription Dermatological Drugs Business Revenue Market Share (2013-2018)
Table F. Hoffmann-La Roche Basic Information List
Table Prescription Dermatological Drugs Business Revenue (Million USD) of F. Hoffmann-La Roche (2013-2018)
Figure F. Hoffmann-La Roche Prescription Dermatological Drugs Business Revenue Market Share (2013-2018)
Table Allergan Basic Information List
Table Prescription Dermatological Drugs Business Revenue (Million USD) of Allergan (2013-2018)
Figure Allergan Prescription Dermatological Drugs Business Revenue Market Share (2013-2018)
Table Valeant Pharmaceuticals Basic Information List
Table Prescription Dermatological Drugs Business Revenue (Million USD) of Valeant Pharmaceuticals (2013-2018)
Figure Valeant Pharmaceuticals Prescription Dermatological Drugs Business Revenue Market Share (2013-2018)
Table PharmaDerm Pharmaceuticals Basic Information List
Table Prescription Dermatological Drugs Business Revenue (Million USD) of PharmaDerm Pharmaceuticals (2013-2018)
Figure PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Business Revenue Market Share (2013-2018)
Table Allergan Inamed Corporation Basic Information List
Table Prescription Dermatological Drugs Business Revenue (Million USD) of Allergan Inamed Corporation (2013-2018)
Figure Allergan Inamed Corporation Prescription Dermatological Drugs Business Revenue Market Share (2013-2018)
Table Global Prescription Dermatological Drugs Market Size (Million USD) by Product (2013-2018)
Figure Global Prescription Dermatological Drugs Revenue Market Share (%) by Product (2013-2018)
Figure Global Prescription Dermatological Drugs Market Share by Product in 2017
Table Global Prescription Dermatological Drugs Market Size by Application (2013-2018)
Figure Global Prescription Dermatological Drugs Revenue Market Share (%) by Application in 2017
Table Top Consumer/End Users of Prescription Dermatological Drugs
Figure United States Prescription Dermatological Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table United States Prescription Dermatological Drugs Market Size (Million USD) by Players (2013-2018)
Figure United States Prescription Dermatological Drugs Market Size Share by Players in 2013
Figure United States Prescription Dermatological Drugs Market Size Share by Players in 2017
Table United States Prescription Dermatological Drugs Market Size by Application (2013-2018)
Figure United States Prescription Dermatological Drugs Revenue Market Share (%) by Application (2013-2018)
Figure United States Prescription Dermatological Drugs Market Size Share by Application in 2017
Figure Europe Prescription Dermatological Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table Europe Prescription Dermatological Drugs Market Size (Million USD) by Players (2013-2018)
Figure Europe Prescription Dermatological Drugs Market Size Share by Players in 2013
Figure Europe Prescription Dermatological Drugs Market Size Share by Players in 2017
Table Europe Prescription Dermatological Drugs Market Size by Application (2013-2018)
Figure Europe Prescription Dermatological Drugs Revenue Market Share (%) by Application (2013-2018)
Figure Europe Prescription Dermatological Drugs Market Size Share by Application in 2017
Figure China Prescription Dermatological Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table China Prescription Dermatological Drugs Market Size (Million USD) by Players (2013-2018)
Figure China Prescription Dermatological Drugs Market Size Share by Players in 2013
Figure China Prescription Dermatological Drugs Market Size Share by Players in 2017
Table China Prescription Dermatological Drugs Market Size by Application (2013-2018)
Figure China Prescription Dermatological Drugs Revenue Market Share (%) by Application (2013-2018)
Figure China Prescription Dermatological Drugs Market Size Share by Application in 2017
Figure Japan Prescription Dermatological Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table Japan Prescription Dermatological Drugs Market Size (Million USD) by Players (2013-2018)
Figure Japan Prescription Dermatological Drugs Market Size Share by Players in 2013
Figure Japan Prescription Dermatological Drugs Market Size Share by Players in 2017
Table Japan Prescription Dermatological Drugs Market Size by Application (2013-2018)
Figure Japan Prescription Dermatological Drugs Revenue Market Share (%) by Application (2013-2018)
Figure Japan Prescription Dermatological Drugs Market Size Share by Application in 2017
Figure Southeast Asia Prescription Dermatological Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table Southeast Asia Prescription Dermatological Drugs Market Size (Million USD) by Players (2013-2018)
Figure Southeast Asia Prescription Dermatological Drugs Market Size Share by Players in 2013
Figure Southeast Asia Prescription Dermatological Drugs Market Size Share by Players in 2017
Table Southeast Asia Prescription Dermatological Drugs Market Size by Application (2013-2018)
Figure Southeast Asia Prescription Dermatological Drugs Revenue Market Share (%) by Application (2013-2018)
Figure Southeast Asia Prescription Dermatological Drugs Market Size Share by Application in 2017
Figure India Prescription Dermatological Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table India Prescription Dermatological Drugs Market Size (Million USD) by Players (2013-2018)
Figure India Prescription Dermatological Drugs Market Size Share by Players in 2013
Figure India Prescription Dermatological Drugs Market Size Share by Players in 2017
Table India Prescription Dermatological Drugs Market Size by Application (2013-2018)
Figure India Prescription Dermatological Drugs Revenue Market Share (%) by Application (2013-2018)
Figure India Prescription Dermatological Drugs Market Size Share by Application in 2017
Figure Global Prescription Dermatological Drugs Market Size and Growth Rate (2018-2025)
Table Global Prescription Dermatological Drugs Market Size (Million USD) by Regions (2018-2025)
Figure Global Prescription Dermatological Drugs Market Size Share (2018-2025)
Figure Global Prescription Dermatological Drugs Market Size Share by Regions in 2025
Figure United States Prescription Dermatological Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure Europe Prescription Dermatological Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure China Prescription Dermatological Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure Japan Prescription Dermatological Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure Southeast Asia Prescription Dermatological Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure India Prescription Dermatological Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Table Global Prescription Dermatological Drugs Market Size (Million USD) by Type (2018-2025)
Figure Global Prescription Dermatological Drugs Market Size Share by Type in 2018
Figure Global Prescription Dermatological Drugs Market Size Share by Type in 2025
Table Global Prescription Dermatological Drugs Market Size (Million USD) by Application (2018-2025)
Figure Global Prescription Dermatological Drugs Market Size (Million USD) by Application in 2018
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Contrast Media (Contrast Agents) Market 2018, Forecast to 2023
    Published: 17-Aug-2018        Price: US 4880 Onwards        Pages: 137
    Contrast media (or contrast agents) is a substance used to increase the contrast of structures or fluids within the body in medical imaging. Contrast agents absorb or alter external electromagnetism or ultrasound, which is different from radiopharmaceuticals, which emit radiation themselves. Contrast media, enhance the radiodensity in a target tissue or structure. Contrast agents are commonly used to improve the visibility of blood vessels and the gastrointestinal tract. Several ty......
  • Global Contrast Media (Contrast Agents) Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 17-Aug-2018        Price: US 3480 Onwards        Pages: 133
    Contrast media (or contrast agents) is a substance used to increase the contrast of structures or fluids within the body in medical imaging. Contrast agents absorb or alter external electromagnetism or ultrasound, which is different from radiopharmaceuticals, which emit radiation themselves. Contrast media, enhance the radiodensity in a target tissue or structure. Contrast agents are commonly used to improve the visibility of blood vessels and the gastrointestinal tract. Several ty......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Closed System Drug Transfer Device (CSTD) Market 2018, Forecast to 2023
    Published: 17-Aug-2018        Price: US 4880 Onwards        Pages: 135
    Closed System Drug Transfer Device (CSTD) is a drug transfer device that mechanically prohibits the transfer of environmental contaminants into a system and the escape of hazardous drug or vapor concentrations outside the system, which designed to prevent the escape of hazardous drug vapors into the environment during drug reconstitution and administration. Scope of the Report: This report focuses on the Closed System Drug Transfer Device (CSTD) in global market, especially......
  • Global Closed System Drug Transfer Device (CSTD) Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 17-Aug-2018        Price: US 3480 Onwards        Pages: 130
    Closed System Drug Transfer Device (CSTD) is a drug transfer device that mechanically prohibits the transfer of environmental contaminants into a system and the escape of hazardous drug or vapor concentrations outside the system, which designed to prevent the escape of hazardous drug vapors into the environment during drug reconstitution and administration. Scope of the Report: This report focuses on the Closed System Drug Transfer Device (CSTD) in global market, especially......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Auto-Injectors Market 2018, Forecast to 2023
    Published: 17-Aug-2018        Price: US 4880 Onwards        Pages: 132
    Auto-injector is a medical device designed to deliver a dose of a particular drug. Most auto-injectors are spring-loaded syringes. By design, auto-injectors are easy to use and are intended for self-administration by patients, or administration by untrained personnel. The site of injection depends on the drug loaded, but it typically is administered into the thigh or the buttocks. Scope of the Report: This report focuses on the Auto-Injectors in global market, especi......
  • Global Auto-Injectors Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 17-Aug-2018        Price: US 3480 Onwards        Pages: 136
    Auto-injector is a medical device designed to deliver a dose of a particular drug. Most auto-injectors are spring-loaded syringes. By design, auto-injectors are easy to use and are intended for self-administration by patients, or administration by untrained personnel. The site of injection depends on the drug loaded, but it typically is administered into the thigh or the buttocks. Scope of the Report: This report focuses on the Auto-Injectors in global market, especi......
  • Global Viral Vectors and Plasmid DNA Manufacturing Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 17-Aug-2018        Price: US 3480 Onwards        Pages: 150
    The viral vectors and plasmid DNA is used for the treatment of cancers, inherited disorders, viral infections and other diseases. Scope of the Report: This report studies the Viral Vectors and Plasmid DNA Manufacturing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Viral Vectors and Plasmid DNA Manufacturing market by product typ......
  • Global and India Bone Sonometers Market Research by Company, Type & Application 2013-2025
    Published: 16-Aug-2018        Price: US 2000 Onwards        Pages: 114
    Summary A bone sonometer is a device that transmits ultrasound energy into the human body to measure acoustic properties of bone that indicate overall bone health and fracture risk. A bone densitometer is a device intended for medical purposes to measure bone density and mineral content by X-ray or gamma ray transmission measurements through the bone and adjacent tissues. The primary components of the device are a voltage generator, a transmitting transducer, a receiving transducer, and h......
  • Global and India Metal Biliary Stent Market Research by Company, Type & Application 2013-2025
    Published: 16-Aug-2018        Price: US 2000 Onwards        Pages: 105
    Summary The most common indication for biliary stenting is for treatment of obstructive jaundice from either benign or malignant causes. On occasion, stents are placed for management of bile leaks. Stents are made of either plastic or metal, and they are placed to provide internal drainage, eliminating the need for an external catheter. Market Segment as follows: By Type - Covered Metal Biliary Stent - Uncovered Metal Biliary Stent By Application ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs